Patient Discovery Partners with AmerisourceBergen for Cancer Care Equity
Patient Discovery Solutions, a leader in health equity solutions that harness the power of patient-centered technology and real-world data to help achieve better health outcomes, joins the Trusted Vendor Program by global healthcare company AmerisourceBergen. The collaboration enables community oncology practices, hospitals, and health systems nationwide access to Patient Discovery’s Equitable Care Platform, allowing care providers to proactively identify and address social determinants of health to better inform providers and help improve outcomes for cancer patients.
AmerisourceBergen’s Trusted Vendor Program is comprised of a portfolio of cutting-edge operational and clinical care solutions. As a partner, Patient Discovery’s Equitable Care Platform will seamlessly integrate within a participating practice’s current systems, helping to improve information exchange for delivering equitable care across multiple sites of care. Care teams across the country are burned out and stretched thin. The Patient Discovery platform reduces the burden of discovery by collecting real-world patient-reported data on health-related social needs, like housing, food security, and transportation, giving clinicians immediate access to these insights. This strategic partnership has the capacity to deliver national action on health equity.
“It’s widely understood that clinical outcomes are heavily influenced by what happens outside of the clinic,” said Norm Shore, CEO and Co-Founder at Patient Discovery. “To effectively reduce disparities in healthcare, we need to remove the burden of discovery from providers and efficiently bridge the gap between the patient’s lived experiences and their clinical care path.”
Addressing health equity has become a leading priority nationwide, with 89 percent of healthcare executives prioritizing health equity programs as part of their core business strategy. Patient Discovery’s mission to merge the patient’s life outside the clinical setting with their clinical care path aligns perfectly with AmerisourceBergen’s corporate priority to advance health equity.
“The healthcare industry needs practical solutions that integrate into the clinical workflow of a practice and help aggregate and normalize data on social determinants of health. We look forward to bringing our team’s passion and the power of our network to utilize the Patient Discovery equitable care platform to advance health equity in a more meaningful way,” said Charley Deckers, VP, Business Development and Alliances, Specialty Physician Services at AmerisourceBergen.
Moving forward, this new platform will enable care teams to deliver targeted care plans aimed at the whole person, improving the patient experience, and reducing the total cost of care.
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more